Researchers from Queen Mary University of London have developed an AI tool that creates synthetic yet medically accurate models of fibrotic heart tissue (heart scarring), aiding treatment planning for ...

Innoblative Designs announced today that it received FDA investigational device exemption (IDE) for its Sira RFA ...

The US Food and Drug Administration (FDA) has granted approval for Innoblative Designs' investigational device exemption (IDE ...

The US Ablation Technology Market is projected to reach US$3.87 billion by 2030 from US$2.44 billion in 2025, at a CAGR of 9.6%. The US ablation ...

Despite promising technology and FDA clearances, Pulse Biosciences lacks a revenue stream and remains in the testing phase ...

Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with ...

The University of Arkansas for Medical Sciences (UAMS) recently became the first provider in Arkansas of NanoKnife technology ...